Role of Macronutrient Diet Composition and Infant Metabolic Outcomes in Gestational Diabetes
1 other identifier
interventional
35
1 country
1
Brief Summary
A better understanding of the optimal diet for women with gestational diabetes is fundamental to the management of this rapidly growing problem in pregnancy. Careful comparison studies of the current low- carbohydrate, higher-fat diet versus a diet higher in complex carbohydrate but lower in fat is critical in order to determine which diet results in a more favorable maternal 24-hour glucose, lipid, and inflammatory profile, all of which directly effect optimal fetal growth and may influence the future health of the offspring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2007
CompletedFirst Submitted
Initial submission to the registry
October 29, 2012
CompletedFirst Posted
Study publicly available on registry
November 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedJune 10, 2015
June 1, 2015
7.5 years
October 29, 2012
June 8, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glucose area-under-the-curve
The average glucose area-under-the-curve over 3 days, calculated using 24-hour continuous glucose monitoring
During 3 days of each diet treatment
Secondary Outcomes (1)
Infant Adiposity
2 weeks after birth
Study Arms (2)
Conventional Diet
EXPERIMENTALLow carbohydrate/higher fat diet: 40% carbohydrate, 45% fat, 15% protein
Complex Carbohydrate Diet
EXPERIMENTALHigh complex carbohydrate/lower fat diet: 60% complex carbohydrate, 25% fat, 15% protein
Interventions
Eligibility Criteria
You may qualify if:
- A 50-gram Glucola in which the one hour reading is \>200 mg/dL and the FBG is \>95 mg/dL
- Two abnormal values on a 100-gram 3 hour glucose tolerance test based on the Coustan and Carpenter criteria as adopted by the ADA and Fourth International Workshop on Gestational Diabetes (76;77):
- Fasting \> or = to 95 mg/dL but \<126 mg/dL
- hr \>/= 180 mg/dL
- hr \>/= 155 mg/dL
- hr \>/=140 mg/dL
You may not qualify if:
- Fasting glucose \>110 mg/dL, due to the high likelihood of rapidly failing diet and requiring medical treatment (35).
- Random glucose \> 200 mg/dL
- Glycosylated hemoglobin A1C \> 6.5
- Non-English speaking patient
- Fasting TG \> 400 mg/dL
- Women who smoke will be excluded since this is the leading cause of low birth weight. In addition, women with other risk factors for placental insufficiency, including hypertension requiring beta-blocker treatment, renal disease, thrombophilias, preeclampsia, steroid use, history of pancreatitis or infectious disease such as hepatitis, or intrauterine growth restriction will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Colorado, Denverlead
- Kaiser Permanentecollaborator
Study Sites (1)
University of Colorado, Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Related Publications (1)
Hernandez TL, Van Pelt RE, Anderson MA, Reece MS, Reynolds RM, de la Houssaye BA, Heerwagen M, Donahoo WT, Daniels LJ, Chartier-Logan C, Janssen RC, Friedman JE, Barbour LA. Women With Gestational Diabetes Mellitus Randomized to a Higher-Complex Carbohydrate/Low-Fat Diet Manifest Lower Adipose Tissue Insulin Resistance, Inflammation, Glucose, and Free Fatty Acids: A Pilot Study. Diabetes Care. 2016 Jan;39(1):39-42. doi: 10.2337/dc15-0515. Epub 2015 Jul 29.
PMID: 26223240DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 29, 2012
First Posted
November 1, 2012
Study Start
August 1, 2007
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
June 10, 2015
Record last verified: 2015-06